Stockreport

Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth [Yahoo! Finance]

Bausch + Lomb Corporation Common Shares  (BLCO) 
PDF Bausch + Lomb Corporation (NYSE: BLCO ) is one of the best Canadian stocks to buy under $20 . On February 18, Bausch + Lomb reported record financial results for Q4 202 [Read more]